Array
(
[id] => 4759966
[patent_doc_number] => 20080312192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases'
[patent_app_type] => utility
[patent_app_number] => 10/580259
[patent_app_country] => US
[patent_app_date] => 2004-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49010
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312192.pdf
[firstpage_image] =>[orig_patent_app_number] => 10580259
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/580259 | Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases | Nov 25, 2004 | Abandoned |
Array
(
[id] => 8577770
[patent_doc_number] => 08343981
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-01
[patent_title] => 'Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents'
[patent_app_type] => utility
[patent_app_number] => 10/556198
[patent_app_country] => US
[patent_app_date] => 2004-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14240
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10556198
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556198 | Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents | Apr 27, 2004 | Issued |
Array
(
[id] => 6967182
[patent_doc_number] => 20050234079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Novel crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy] benzyl]thiazolidine-2,4-dione potassium salt'
[patent_app_type] => utility
[patent_app_number] => 10/507399
[patent_app_country] => US
[patent_app_date] => 2003-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5366
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20050234079.pdf
[firstpage_image] =>[orig_patent_app_number] => 10507399
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/507399 | Crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt | Mar 13, 2003 | Issued |